All Names: Ceritinib,LDK378,Zykadia,spexib
Indications:Non-Small Cell Lung Cancer
Manufacturer:Drug International,Bangladesh
Customs Clearance Procedure:If the customs requires the package for customs clearance, please pay the customs clearance fee according to the content of EMS SMS and customs regulations.
INDICATIONS AND USAGE(适应症)
ZYKADIA® is indicated for the treatment of adult patients with metastatic non-small cell lung cancer (NSCLC) whose tumors are anaplastic lymphoma kinase (ALK)-positive as detected by an FDA-approved test.
DOSAGE(服用剂量)
The recommended dosage of ZYKADIA is 450 mg orally once daily with food until disease progression or unacceptable toxicity.
If a dose of ZYKADIA is missed, make up that dose unless the next dose is due within 12 hours.
If vomiting occurs during the course of treatment, do not administer an additional dose and continue with the next scheduled dose of ZYKADIA.
ADVERSE REACTIONS(不良反应)
Gastrointestinal Adverse Reactions
Hepatotoxicity
Interstitial Lung Disease/Pneumonitis
QT Interval Prolongation
Hyperglycemia
Bradycardia
Pancreatitis
For full information, please refer to:
https://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/fff5d805-4ffd-4e8e-8e63-6f129697563e/spl-doc?hl=Ceritinib
Cerinibinformation
No information yet!!!